Published in Naunyn Schmiedebergs Arch Pharmacol on December 04, 2009
Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation. Circ Res (2011) 1.82
Post-operative atrial fibrillation: a maze of mechanisms. Europace (2011) 1.12
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc Health Risk Manag (2011) 0.99
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
Transient outward K+ current reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes. J Physiol (2012) 0.89
Gender differences in electrophysiological gene expression in failing and non-failing human hearts. PLoS One (2013) 0.89
Exercise training improves heart rate variability in older patients with heart failure: a randomized, controlled, single-blinded trial. Congest Heart Fail (2012) 0.87
Prolonged atrial fibrillation following generalized tonic-clonic seizures. Seizure (2012) 0.82
Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade. Pflugers Arch (2011) 0.82
Intraoperative Magnesium Administration Does Not Reduce Postoperative Atrial Fibrillation After Cardiac Surgery. Anesth Analg (2015) 0.82
Effects of human atrial ionic remodelling by β-blocker therapy on mechanisms of atrial fibrillation: a computer simulation. Europace (2014) 0.81
Atrial fibrillation in decompensated heart failure: associated factors and in-hospital outcome. Arq Bras Cardiol (2014) 0.81
Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation. Cardiovasc Res (2013) 0.80
Oscillatory behavior of ventricular action potential duration in heart failure patients at respiratory rate and low frequency. Front Physiol (2014) 0.80
Inhibition of a TREK-like K+ channel current by noradrenaline requires both β1- and β2-adrenoceptors in rat atrial myocytes. Cardiovasc Res (2014) 0.80
Novel pharmacological approaches for antiarrhythmic therapy. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.80
Human atrial fibrillation: insights from computational electrophysiological models. Trends Cardiovasc Med (2011) 0.79
Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic. Heart Vessels (2015) 0.79
CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy. PLoS One (2013) 0.78
Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study. Clin Res Cardiol (2014) 0.77
Denervation as a common mechanism underlying different pulmonary vein isolation strategies for paroxysmal atrial fibrillation: evidenced by heart rate variability after ablation. ScientificWorldJournal (2013) 0.77
A Computer Simulation Study of Anatomy Induced Drift of Spiral Waves in the Human Atrium. Biomed Res Int (2015) 0.76
Aerobic interval training partly reverse contractile dysfunction and impaired Ca2+ handling in atrial myocytes from rats with post infarction heart failure. PLoS One (2013) 0.76
Reversible atrial fibrillation following Crotalinae envenomation. J Venom Anim Toxins Incl Trop Dis (2017) 0.75
Management strategies in cardiac surgery for postoperative atrial fibrillation: contemporary prophylaxis and futuristic anticoagulant possibilities. Cardiol Res Pract (2013) 0.75
Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill. Crit Care (2016) 0.75
Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines. Arq Bras Cardiol (2016) 0.75
Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how? Heart Rhythm (2010) 0.75
Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation. PLoS One (2017) 0.75
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22
Cardiac excitation-contraction coupling. Nature (2002) 18.48
Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol (2008) 6.19
A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA (2004) 5.20
Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm (2005) 3.55
Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res (2007) 3.46
Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol (1998) 3.41
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation (2005) 3.31
Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation (2002) 3.22
Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res (1999) 3.22
Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J (2004) 3.14
Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol (2003) 2.62
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol (2002) 2.50
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol (2005) 2.43
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res (2001) 2.41
Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res (1997) 2.38
Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res (1999) 2.37
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm (2007) 2.18
Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation (2005) 2.15
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res (1988) 2.13
Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation. Circulation (2003) 2.06
Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation (2004) 1.97
Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol (1990) 1.89
L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation (2004) 1.85
Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation (2000) 1.83
Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol (2004) 1.79
Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure. J Cardiovasc Electrophysiol (2003) 1.78
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77
The action of acetylcholine and epinephrine on the cellular membrane potentials and contractility of rat atrium. Circ Res (1956) 1.75
Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation (2003) 1.73
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res (2000) 1.68
Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res (1994) 1.67
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Intracellular calcium dynamics and anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation (2005) 1.65
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res (2003) 1.62
Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.62
Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation (2001) 1.58
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol (2000) 1.58
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation (2002) 1.58
Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation. Eur Heart J (2008) 1.55
What role does modulation of the ryanodine receptor play in cardiac inotropy and arrhythmogenesis? J Mol Cell Cardiol (2008) 1.55
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol (2006) 1.53
Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol (2008) 1.53
Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression. Cardiovasc Res (2005) 1.48
The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction. J Cell Sci (2004) 1.47
Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation (2001) 1.45
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart (2007) 1.44
beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes. Cardiovasc Res (2002) 1.44
Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation (2000) 1.42
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation (1997) 1.37
The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res (1986) 1.34
Protein kinase C enhances the rapidly activating delayed rectifier potassium current, IKr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes. J Physiol (2000) 1.33
Novel approaches for pharmacological management of atrial fibrillation. Drugs (2009) 1.32
Differences in intracellular calcium homeostasis between atrial and ventricular myocytes. J Mol Cell Cardiol (2008) 1.30
The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl) (2005) 1.29
Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation. Circulation (2003) 1.29
Na(+)-Ca2+ exchange current in latent pacemaker cells isolated from cat right atrium. J Physiol (1993) 1.29
High frequency-induced upregulation of human cardiac calcium currents. Circulation (1996) 1.28
Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res (2008) 1.27
Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol (1998) 1.26
Electrophysiological study of human heart muscle. Circ Res (1962) 1.26
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol (1996) 1.22
Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. Circ Res (1996) 1.20
Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment. Br J Pharmacol (1988) 1.20
Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia. Nature (1977) 1.16
Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J Cardiovasc Pharmacol (2008) 1.15
Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation. Basic Res Cardiol (2002) 1.14
Triggered activity and atrial fibrillation. Heart Rhythm (2006) 1.10
Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium. Circ Res (2001) 1.10
The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord (1999) 1.08
Localization of f-channels to caveolae mediates specific beta2-adrenergic receptor modulation of rate in sinoatrial myocytes. J Mol Cell Cardiol (2006) 1.05
Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis. Circulation (2005) 1.05
Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation. Pacing Clin Electrophysiol (2006) 1.05
Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J Mol Cell Cardiol (2008) 1.03
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol (2006) 1.03
Atrial L-type Ca2+-channel, beta-adrenorecptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res Cardiol (2001) 1.02
Both beta 1- and beta 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.01
Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochem Biophys Res Commun (2004) 1.00
The arrhythmogenic actions of histamine on human atrial fibers. Circ Res (1981) 1.00
Characterization of the hyperpolarization-activated inward current in isolated human atrial myocytes. Cardiovasc Res (1998) 0.99
Beta-2 adrenergic activation of L-type Ca++ current in cardiac myocytes. J Pharmacol Exp Ther (1997) 0.98
Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther (1985) 0.98
beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J Clin Invest (1995) 0.98
Characteristics of initiation and termination of catecholamine-induced triggered activity in atrial fibers of the coronary sinus. Circulation (1986) 0.98
Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol (1995) 0.97
Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. J Physiol (1982) 0.97
Downregulation of cardiac guanosine 5'-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest (1993) 0.95
Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors. Circulation (1993) 0.95
Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. role of phosphatase 2A. Cardiovasc Res (2003) 0.94
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Modulation of delayed rectifier potassium current, iK, by isoprenaline in rabbit isolated pacemaker cells. Exp Physiol (2000) 0.94
L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol (2001) 0.93
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Br J Pharmacol (2003) 0.92